PetVivo Holdings PETV
OTC PETV
$0.70 +0.01 (+1.85%)
As of: Oct 23, 2026 · 1:04 PM EDT

PetVivo Holdings (PETV) Amortization of Deferred Charges (2016 - 2026)

Updated

Analysis

PetVivo Holdings (PETV) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 PetVivo Holdings 25.94 Mn 24.68 Mn 223,317.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16,057.00
Mar 31, 2026 912,903.00
Dec 31, 2025 2,956.00
Sep 30, 2025 870,293.00
Jun 30, 2025 66,259.00
Mar 31, 2025 178,623.00
Mar 31, 2021 1,421.00
Dec 31, 2020 24,890.00
Sep 30, 2020 128,676.00
Jun 30, 2020 19,608.00
Jun 30, 2016 3,311.00
API Access

PetVivo Holdings Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PETV&period=max&api_key=YOUR_API_KEY